Bayer AG - Stockholders' Newsletter Third Quarter 2008

News

New fungicide Infinito®
Innovative fungicide saves potato harvest
A fungus by the name of Phytophthora infestans has been destroying potato harvests throughout the world for many a year. Yet the fungus can be stopped. » more

5:47 min.

Molecular imaging
On the trail of Alzheimer’s disease
Since the beginning of September, Bayer HealthCare has been collaborating with the University of Nagasaki, Japan, in the search for special tracers to diagnose Alzheimer’s disease. » more

Agerelated macular degeneration (AMD)
Improving vision with VEGF Trap-Eye
VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters of pathological blood vessel formation. » more

1:20 min.

Tobacco for medicines
Industrial-scale pharmaceutical production from tobacco
Bayer Innovation GmbH and Kentucky Bioprocessing, LLC (KBP) have agreed to develop a facility for the production of biopharmaceuticals in Owensboro, Kentucky. » more

News Overview

Key Data
Bayer Group
Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees » more

Bayer Stock Key Data
Investor Information
In the third quarter of 2008 the stock market was dominated by the effects of the international financial crisis, with the dax down nearly 8 percent on the period. » more

Management Report
Overview of Sales, Earnings and Financial Position
Bayer continued on its path of growth in the third quarter of 2008. Sales rose by 2.0 percent to €7,948 million (Q3 2007: €7,793 million). » more

Focus
Anticoagulant Xarelto registered in the European Union
At the end of September, the European Commission granted marketing authorization for the innovative anticoagulant Xarelto®. » more

1:48 min.